Cyclooxygenase 2 Inhibitors: all 667 studies that test it

Page 4 of 7. Open to participants first (39), then studies with results posted, then the rest; newest registration first within each.

• Tramadol Versus Celecoxib for Reducing Pain During Office Hysteroscopy in Post Menopausal WomenStatus unknownNCT02736019Phase 3
• Parecoxib for Treatment of Catheter Related Bladder DiscomfortCompletedNCT02729935Phase 4
• Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum DepressionTerminatedNCT02726659Phase 3
• Impact of Celecoxib on Electrophysiological Property in Brain of Healthy VolunteerCompletedNCT02711579Phase 1
• Treatment of Recent Onset Low Back Pain With Periradicular Injections of MeloxicamCompletedNCT02706054Phase 3
• Minocycline and Celecoxib as Adjunctive Treatments of Bipolar DepressionCompletedNCT02703363Phase 3
• Correlation Between Acute Analgesia and Long-Term Function Following Ankle InjuriesCompletedNCT02667730Phase 4
• A Study of Type-1 Polarized Dendritic Cell (αDC1) Vaccine in Combination With Tumor-Selective Chemokine Modulation (Interferon-α2b, Rintatolimod, and Celecoxib) in Subjects With Chemo-Refractory Metastatic Colorectal CancerWithdrawnNCT02615574Phase 2
• Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative ShiveringCompletedNCT02569905Phase 4
• Dexketoprofen and Etoricoxib in Patients Undergoing Hip ArthroplastyCompletedNCT02568735Phase 4
• The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownNCT02537925Phase 3
• Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee ArthroplastyCompletedNCT02534610Not applicable
• Therapeutic Vaccination and Immune Modulation - New Treatment Strategies for the MDR Tuberculosis PandemicCompletedNCT02503839Phase 1
• Effect of AKB-6548 on the Pharmacokinetics of CelecoxibCompletedNCT02502500Phase 1
• Study of Association of Anti-inflammatory and Anti-rheumaticStatus unknownNCT02448199Phase 3
• Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic OsteoarthropathyStatus unknownNCT02438709Phase 3
• The Effect of Parecoxib Sodium Intravenous Patient-controlled Analgesia in Laparotomic Liver ResectionStatus unknownNCT02408146Not applicable
• Meloxicam SoluMatrix® Capsules vs Meloxicam Tablets to Treat Osteoarthritis PainWithdrawnNCT02405793Phase 2
• ATRA, Celecoxib, and Itraconazole as MaintenanceCompletedNCT02401295Phase 1
• Celecoxib for the Treatment of Non-muscle Invasive Bladder CancerCompletedNCT02343614Phase 2
• Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary AtresiaCompletedNCT02298218Phase 4
• Low Dose Metronomic Poly-chemotherapy for Metastatic CRCCompletedNCT02280694Phase 2
• Parecoxib for Pain Management After Total Knee Arthroplasty and Total Hip ArthroplastyCompletedNCT02272660Phase 4
• Assessment of a Vaginal Ring With Meloxicam in the Treatment of DysmenorrheaCompletedNCT02255045Phase 2/3
• Effect of Acupuncture to Endothelial Dysfunction Induced by Ischemia-reperfusion InjuryStatus unknownNCT02255006Not applicable
• Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or LaryngitisCompletedNCT02229747Phase 4
• Role of Parecoxib Sodium for Postoperative Pain Management in Open HepatectomyStatus unknownNCT02204878Phase 4
• Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis PatientsCompletedNCT02198924Phase 4
• Bioequivalence Study of UHAC62XX Tablets Compared With Capsules in Healthy VolunteersCompletedNCT02187575Phase 1
• Effect of Steady State Meloxicam on Low Dose Aspirin Induced Inhibition of Platelet Aggregation and Thromboxane Synthesis in Healthy Males and FemalesCompletedNCT02187562Phase 1
• Combination of Continuous Femoral Block and Intravenous Parecoxib For Postoperative Analgesia After Total Knee ArthroplastyCompletedNCT02185924Phase 2/3
• Bioequivalence Study of Meloxicam Capsules 15 mg (Mobic® Capsules 15 mg) Versus Meloxicam Tablets 15 mg (Mobic® Tablets 15 mg) in Healthy Adult VolunteersCompletedNCT02183181Phase 1
• Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing SpondylitisCompletedNCT02183168Phase 3
• Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the KneeCompletedNCT02183129Phase 4
• A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the KneeCompletedNCT02183116Phase 4
• Pharmacokinetics and Tolerability of Meloxicam Gel Compared to Meloxicam Tablets in Healthy SubjectsCompletedNCT02183077Phase 1
• Study to Compare Prescription Non-Steroidal Anti-Inflammatory Drug (NSAID) Changes, Health Care Utilization, Efficacy and Safety of Meloxicam 7.5 mg Versus Usual Care Administration of Prescription NSAIDs in a Managed Healthcare Setting in Patients With OsteoarthritisCompletedNCT02183064Phase 3
• Study to Compare the the Analgesic Efficacy and Tolerability of Meloxicam Versus Placebo and Ibuprofen in the Treatment of Pain After Surgery of the Third MolarCompletedNCT02183051Phase 2
• Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With DysmenorrheaCompletedNCT02183025Phase 2
• Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy VolunteersCompletedNCT02181907Phase 1
• Bioequivalence Study of UHAC 62 XX Tablets Compared With Capsules in Healthy VolunteersCompletedNCT02180490Phase 1
• Preliminary Bioequivalence Study of UHAC 62 XX Tablets Compared With a Capsule Formulation in Healthy Male VolunteersCompletedNCT02180477Phase 1
• Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma PatientsWithdrawnNCT02160301Phase 4
• EFFECT OF SELECTIVE COX-2 INHIBITOR (ETORICOXIB) ALONG WITH SCALING AND ROOT PLANING (SRP) ON CLINICAL PARAMETERS AND SALIVARY LEVEL OF SUPEROXIDE DISMUTASE IN CHRONIC GENERALIZED PERIODONTITIS A DOUBLE-BLIND, PLACEBO-CONTROLLED, DOUBLE-MASKED RANDOMIZED CONTROLLED TRIAL (RCT).CompletedNCT02149758Phase 4
• Intravitreal Celecoxib for Chronic UveitisTerminatedNCT02131012Phase 1
• Safety of Fluvastatin-Celebrex Association in Low-grade and High Grade Optico-chiasmatic GliomasCompletedNCT02115074Phase 1
• Decreasing Narcotics in Advanced Pelvic SurgeryCompletedNCT02110719Phase 4
• Treatment of Severe Influenza A InfectionCompletedNCT02108366Phase 3
• Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02099136Phase 2
• Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy VolunteersCompletedNCT02090933Phase 2
• Tramadol Versus Celecoxib for Reducing Pain in Outpatient HysteroscopyCompletedNCT02071303Phase 2
• TB-IRIS NSAID Cox-2 Inhibitor Prevention TrialStatus unknownNCT02060006Phase 3
• N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/TopotecanCompletedNCT02030964Phase 1
• Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing SpondylitisCompletedNCT01934933Phase 4
• Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance After Gastrointestinal Laparoscopic SurgeryStatus unknownNCT01930318Phase 4
• Window of Opportunity Study Targeting the Inflammatory MilieuCompletedNCT01881048Early Phase 1
• NSAID Treatment in Knee OsteoarthritisCompletedNCT01860833Phase 4
• Efficacy Parecoxib and Ketorolac as Preemptive Analgesia in Spine FusionCompletedNCT01859585Phase 4
• Effect of Parecoxib on the Change of Shoulder Pain Threshold After Gynecological LaparoscopiesCompletedNCT01843010Phase 4
• Assessment of a Vaginal Ring With Meloxicam on Ovarian Cycle in Fertile WomenCompletedNCT01839643Phase 1
• Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed ConditionCompletedNCT01831687Phase 1
• Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting ConditionCompletedNCT01827865Phase 1
• Urinary NGF as A Biomarker for Acute Bacterial CystitisCompletedNCT01800799Not applicable
• Low Dose Aspirin Inhibition of COX-2 Derived PGE2 in Male SmokersCompletedNCT01796951Early Phase 1
• CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and AcetaminophenCompletedNCT01762891Not applicable
• ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic TumorsCompletedNCT01756989Phase 2
• Randomized Controlled Phase II Trial of Pre-operative Celecoxib Treatment in Breast CancerCompletedNCT01695226Phase 2
• Maintenance Metronomic Chemotherapy for Metastatic Colorectal CarcinomaTerminatedNCT01668680Phase 2
• Celecoxib for Primary Prophylaxis of Combat-Related Heterotopic OssificationStatus unknownNCT01631669Not applicable
• Statins and Selective Cyclooxygenase-2 Receptor Inhibitors in Blunt Chest TraumaStatus unknownNCT01623921Not applicable
• Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute LumbagoWithdrawnNCT01587508Phase 3
• Efficacy and Safety of Parecoxib on Morphine Patient-controlled Epidural Analgesia (PCEA) After Gynecologic SurgeryCompletedNCT01566669Not applicable
• The Pharmacokinetic Interaction Between Celecoxib and RebamipideCompletedNCT01549743Phase 1
• NSAIDs With Morphine-PCA Compared to Epidural Analgesia in Thoracotomy PainCompletedNCT01541137Not applicable
• Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)Status unknownNCT01503385Phase 2
• Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for ArthralgiaTerminatedNCT01481610Phase 2
• Efficacy, Safety and Tolerability Study of N1539 in Subjects After Abdominal Laparoscopic SurgeryTerminatedNCT01436032Phase 3
• A Study of Etoricoxib in Participants With Osteoarthritis Not Responding to Analgesic Drugs (MK-0663-142)WithdrawnNCT01429168Phase 4
• Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin InhibitorsCompletedNCT01425476Phase 1/2
• Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy.CompletedNCT01393925Not applicable
• COX-2 Inhibitor Versus Glucocorticoid Versus Both CombinedCompletedNCT01361789Phase 4
• Study of a COX-2 Inhibitor for Prevention of OvulationStatus unknownNCT01346137Phase 2
• Evaluation of the Efficacy and Tolerability of Etoricoxib Monotherapy Versus Combination Oxycodone-etoricoxib in Moderate to Severe Pain From Chronic Low Back PainStatus unknownNCT01344720Phase 4
• Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal MorphineCompletedNCT01344213Phase 4
• Tumor Cell Vaccines and ISCOMATRIX With Chemotherapy After Tumor RemovalTerminatedNCT01341496Phase 1
• Tumor Cell Vaccine for Patients Undergoing Surgery for Sarcomas, Melanomas, Germ Cell Tumors, or Malignancies That Have Metastasized to the Lungs, Pleura, or MediastinumTerminatedNCT01313429Phase 1
• Effect of Celecoxib and Etoricoxib on the Pharmacokinetics and Pharmacodynamics of Oral TramadolCompletedNCT01304069Phase 1
• Effect of an Anti-inflammatory on Tooth Sensitivity Caused by BleachingCompletedNCT01300780Not applicable
• Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?CompletedNCT01288924Phase 2
• A Clinical Trial Using Metronomic Oral Low-dose Cyclophosphamide Alternating With Low-dose Oral Methotrexate With Continuous Celecoxib and Weekly Vinblastine in Children and Adolescents With Relapsed or Progressing soliD Tumours.CompletedNCT01285817Phase 2
• Study of Etoricoxib for the Treatment of Muscle Pain and Inflammation Induced by Eccentric ExerciseCompletedNCT01271348Phase 1
• Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected PatientsCompletedNCT01269515Phase 2
• Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic PainStatus unknownNCT01264237Phase 4
• Effectiveness of Etoricoxib as an Additive Analgesic to Epidural Analgesia in Colon or Rectal Fast-track SurgeryTerminatedNCT01259830Phase 4
• Tumor Cell Vaccines With ISCOMATRIX Adjuvant and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers and Malignant Pleural MesotheliomasTerminatedNCT01258868Phase 1
• Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee ArthroplastyCompletedNCT01246362Phase 2
• Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip ArthroplastyCompletedNCT01229774Phase 3
• Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative PainStatus unknownNCT01221025Phase 4
• MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle SprainsCompletedNCT01198834Phase 3
• A Study Comparing Etoricoxib and Diclofenac Sodium in Post Hallux Valgus Surgery PainWithdrawnNCT01190722Phase 4

← Cyclooxygenase 2 Inhibitors overview